92 related articles for article (PubMed ID: 23094992)
1. New adamantane phenylalkylamines with σ-receptor binding affinity and anticancer activity, associated with putative antagonism of neuropathic pain.
Riganas S; Papanastasiou I; Foscolos GB; Tsotinis A; Serin G; Mirjolet JF; Dimas K; Kourafalos VN; Eleutheriades A; Moutsos VI; Khan H; Georgakopoulou S; Zaniou A; Prassa M; Theodoropoulou M; Mantelas A; Pondiki S; Vamvakides A
J Med Chem; 2012 Nov; 55(22):10241-61. PubMed ID: 23094992
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, σ₁, σ₂-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes.
Riganas S; Papanastasiou I; Foscolos GB; Tsotinis A; Bourguignon JJ; Serin G; Mirjolet JF; Dimas K; Kourafalos VN; Eleutheriades A; Moutsos VI; Khan H; Georgakopoulou S; Zaniou A; Prassa M; Theodoropoulou M; Pondiki S; Vamvakides A
Bioorg Med Chem; 2012 May; 20(10):3323-31. PubMed ID: 22512908
[TBL] [Abstract][Full Text] [Related]
3. New adamantane derivatives with sigma affinity and antiproliferative activity.
Riganas S; Papanastasiou I; Foscolos GB; Tsotinis A; Dimas K; Kourafalos VN; Eleutheriades A; Moutsos VI; Khan H; Margarita P; Georgakopoulou S; Zaniou A; Theodoropoulou M; Mantelas A; Pondiki S; Vamvakides A
Med Chem; 2012 Jul; 8(4):569-86. PubMed ID: 22530894
[TBL] [Abstract][Full Text] [Related]
4. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1, 6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl]diamantane (DPD), a reactive oxygen species and apoptosis inducing agent, on human leukemia cells in vitro and in vivo.
Chang YF; Chi CW; Chern YT; Wang JJ
Toxicol Appl Pharmacol; 2005 Jan; 202(1):1-12. PubMed ID: 15589971
[TBL] [Abstract][Full Text] [Related]
6. A novel atypical retinoid endowed with proapoptotic and antitumor activity.
Cincinelli R; Dallavalle S; Merlini L; Penco S; Pisano C; Carminati P; Giannini G; Vesci L; Gaetano C; Illy B; Zuco V; Supino R; Zunino F
J Med Chem; 2003 Mar; 46(6):909-12. PubMed ID: 12620066
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of thiobenzanilides as anticancer agents.
Hu WP; Yu HS; Chen YR; Tsai YM; Chen YK; Liao CC; Chang LS; Wang JJ
Bioorg Med Chem; 2008 May; 16(9):5295-302. PubMed ID: 18359635
[TBL] [Abstract][Full Text] [Related]
8. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
9. A novel subclass of thalidomide analogue with anti-solid tumor activity in which caspase-dependent apoptosis is associated with altered expression of bcl-2 family proteins.
Marriott JB; Clarke IA; Czajka A; Dredge K; Childs K; Man HW; Schafer P; Govinda S; Muller GW; Stirling DI; Dalgleish AG
Cancer Res; 2003 Feb; 63(3):593-9. PubMed ID: 12566301
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of sigma receptor ligands with unsymmetrical spiro connection of the piperidine moiety.
Jasper A; Schepmann D; Lehmkuhl K; Vela JM; Buschmann H; Holenz J; Wünsch B
Eur J Med Chem; 2009 Nov; 44(11):4306-14. PubMed ID: 19709783
[TBL] [Abstract][Full Text] [Related]
11. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
12. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of somatostatin analogues containing C-terminal adamantane and their antiproliferative properties.
Miyazaki A; Tsuda Y; Fukushima S; Yokoi T; Vántus T; Bökönyi G; Szabó E; Horváth A; Kéri G; Okada Y
J Med Chem; 2008 Aug; 51(16):5121-4. PubMed ID: 18680358
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
[TBL] [Abstract][Full Text] [Related]
15. Insights in Organometallic Synthesis of Various Adamantane Derivatives with Sigma Receptor-Binding Affinity and Antiproliferative/Anticancer Activity.
Papanastasiou I
Methods Mol Biol; 2018; 1824():279-286. PubMed ID: 30039413
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
Yarim M; Koksal M; Schepmann D; Wünsch B
Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo growth inhibition of cancer cells by adamantylmaleimide derivatives.
Wang JJ; Chern YT; Liu TY; Chi CW
Anticancer Drug Des; 1998 Oct; 13(7):779-96. PubMed ID: 9807162
[TBL] [Abstract][Full Text] [Related]
18. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.
Spruce BA; Campbell LA; McTavish N; Cooper MA; Appleyard MV; O'Neill M; Howie J; Samson J; Watt S; Murray K; McLean D; Leslie NR; Safrany ST; Ferguson MJ; Peters JA; Prescott AR; Box G; Hayes A; Nutley B; Raynaud F; Downes CP; Lambert JJ; Thompson AM; Eccles S
Cancer Res; 2004 Jul; 64(14):4875-86. PubMed ID: 15256458
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted apoptosis by a novel spermine analogue, 1,12-diaziridinyl-4,9-diazadodecane, results in therapeutic efficacy and enhanced radiosensitivity of human prostate cancer.
Eiseman JL; Rogers FA; Guo Y; Kauffman J; Sentz DL; Klinger MF; Callery PS; Kyprianou N
Cancer Res; 1998 Nov; 58(21):4864-70. PubMed ID: 9809992
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antiproliferative effect of N-(alkyladamantyl)phthalimides in vitro.
Horvat M; Uzelac L; Marjanović M; Cindro N; Franković O; Mlinarić-Majerski K; Kralj M; Basarić N
Chem Biol Drug Des; 2012 Apr; 79(4):497-506. PubMed ID: 22176512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
